These podcasts are from Meeting of Minds, which is a series of meetings initiated, organised and funded by Takeda in collaboration with a group of international experts in attention-deficit hyperactivity disorder (ADHD).

• Meeting of Minds XV: Optimising the management of ADHD in adults (9–30 November 2023)
• Meeting of Minds XIV: ADHD and comorbid mental health conditions across the lifespan (4–24 November 2022)

This meeting is initiated, organised and funded by Takeda. For healthcare professionals only. The opinions expressed during these podcasts are those of the speaker(s) and may not necessarily reflect those of Takeda. Takeda is not responsible for those opinions or any recommendations made during these podcasts. Pharmacological treatments may be discussed in these podcasts. The availability and approved use of these treatments differs between countries. For further information about the ADHD pharmacological treatments discussed and their associated adverse events, please consult your local prescribing information.